Austin D. Kim is CLO & VP at ACADIA PHARMACEUTICALS INC (ACAD). They have made 15 open-market trades across 1 company since 2019, most recently 2024-01-08.
CIK 0001746240
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACAD | 46,901 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2024-01-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACAD | SELL | 2024-01-08 | 2024-01-09 | $29.96 | $18K | -9.5% | -16.3% | -42.0% |
| ACAD | SELL | 2023-10-06 | 2023-10-06 | $21.96 | $719K | +8.1% | +11.6% | +39.4% |
| ACAD | SELL | 2023-05-01 | 2023-05-02 | $21.18 | $19K | +0.0% | +11.4% | +36.3% |
| ACAD | SELL | 2023-04-06 | 2023-04-07 | $18.16 | $26K | +10.4% | +18.8% | +33.6% |
| ACAD | SELL | 2023-02-24 | 2023-02-27 | $18.78 | $15K | +3.3% | -4.4% | +19.8% |
| ACAD | SELL | 2023-01-09 | 2023-01-10 | $17.13 | $10K | +10.9% | +11.1% | +3.4% |
| ACAD | SELL | 2022-05-02 | 2022-05-03 | $18.18 | $16K | -15.5% | -18.7% | -29.3% |
| ACAD | SELL | 2022-02-23 | 2022-02-25 | $23.80 | $19K | +1.3% | -3.2% | -36.3% |
| ACAD | SELL | 2022-01-06 | 2022-01-10 | $23.05 | $13K | -6.5% | +18.5% | +4.3% |
| ACAD | SELL | 2021-04-30 | 2021-04-30 | $20.33 | $21K | +6.3% | +8.8% | +8.5% |
| ACAD | SELL | 2021-02-04 | 2021-02-08 | $50.61 | $213K | +1.3% | -47.3% | -58.8% |
| ACAD | SELL | 2021-01-06 | 2021-01-08 | $53.34 | $36K | -2.2% | -3.6% | -61.1% |
| ACAD | SELL | 2020-10-27 | 2020-10-29 | $45.10 | $395K | +4.7% | +21.1% | +3.9% |
| ACAD | SELL | 2020-04-30 | 2020-05-01 | $49.22 | $106K | +3.4% | +9.8% | -4.6% |
| ACAD | SELL | 2019-12-11 | 2019-12-13 | $45.06 | $789K | -0.4% | -7.6% | -21.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.